Revna Biosciences
PrivateLast Round
Early Funding
Mar 1, 2026
Total Funding Raised
$108,000
Momentum Score
75 /100
Company Overview
Revna Biosciences is a pre-seed stage biotechnology company developing a novel multi-omics platform for the early detection of complex diseases. Its proprietary technology combines cell-free epigenetics and transcriptomics with machine learning to offer a comprehensive view of disease biology. The company's initial focus is on developing a blood test for the early detection of endometriosis. Founded in 2022, Revna Biosciences aims to empower patients and physicians with innovative tools for early disease detection and management, with a vision of reducing the burden of late-stage diseases.
Sector
Healthcare & Life Sciences
Verticals
Precision Medicine, Biotechnology, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Revna Biosciences Comps
Public and private peers based on sector, stage, and business model.
Revna Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Mar 1, 2026 | ||||
| Grant | Mar 27, 2024 | ||||
| Seed | Nov 11, 2022 |
Revna Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Jaza Rift Ventures | Seed |
| African Diaspora Network | Seed |
| Mirepa Capital | Early Funding |
| develoPPP | Grant |
| Tekedia Capital | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 2, 2026
Monthly visitors increased 439% MoM, reaching 248.
- Mar 1, 2026
Completed an early funding round.
Revna Biosciences Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Revna Biosciences's valuation, stock price, and market status.
